Chargement en cours...
Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and Hydroxychloroquine
BACKGROUND: A new coronavirus SARS-CoV-2 has been identified as the etiological agent of the severe acute respiratory syndrome, COVID-19, the source and cause of the 2019–20 coronavirus pandemic. Hydroxychloroquine and chloroquine have gathered extraordinary attention as therapeutic candidates again...
Enregistré dans:
| Publié dans: | Pharmgenomics Pers Med |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7591012/ https://ncbi.nlm.nih.gov/pubmed/33122936 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S275964 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|